MIST - Milestone Pharmaceuticals Inc. 0 WATCHERS

I’m looking at pharmaceuticals that are up for FDA approval in the next year or two. Examine the fundamentals, keep an eye on the process. Has to be a solid company with a track record. It has to be below a $5 entry for me. Every approval step there’s a …

I got into MIST 2 years ago and now the FDA is supposed to approve it on Dec 13. It’s already starting to runup but I got in at 89 cents and kept buying till $1.90. Now I’m just waiting for the pop where I’ll sell half when it hits …

Curious about MIST. Lets see

Waiting for the RVPH and MIST spikes, surprised it hasn’t done so already considering how close we are

MIST or RVPH?

Premarket watchlist: **$AKAN** : 20% shorted, microscopic float 0.7M , 45% in AH no news. 🔥 **$DEVS** : steady climb into AH, solid news : https://www.businesswire.com/news/home/20251204166343/en/Louisiana-Community-Development-Authority-Authorizes-up-to-%24402-Million-in-Revenue-Bonds-for-Southern-Energy-Renewables-Louisiana-Fuel-Project **$INTS** : looking for Friday dip to add, catalyst (Dec 9-12) solid pipeline: https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$MIST** & **$RVPH** : Anyday.

Premarket watchlist: **$AKAN** : 20% shorted, microscopic float 0.7M , 45% in AH no news. **$DEVS** : steady climb into AH, solid news : https://www.businesswire.com/news/home/20251204166343/en/Louisiana-Community-Development-Authority-Authorizes-up-to-%24402-Million-in-Revenue-Bonds-for-Southern-Energy-Renewables-Louisiana-Fuel-Project **$INTS** : looking for Friday dip to add, catalyst (Dec 9-12) solid pipeline: https://finviz.com/news/245334/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium **$MIST** & **PRPH** : Anyday.

Only RVPH and MIST left to make my year. These are the ones I’ve been waiting for

I'll mark on my calendar to watch for MIST news :)

$MIST DD and Upcoming Catalyst The FDA has set a PDUFA date for CARDAMYST, December 13th, 2025. As of November 2025, $MIST reported $82 million in cash runway. They have a royalty purchase agreement of $75 million that will become payable if CARDAMYST is approved. $MIST has ramped up pre-launch …

RVPH and MIST on the final straight now. In RVPH’s case this could not be better news: https://www.statnews.com/2025/12/04/fda-considers-single-clinical-trial-for-new-product-approvals/

MIST will get approved by the FDA on December 13th.

MIST what we thinking? I think it'll run heavy the next few weeks

My top 5 penny biotechs in order of preference, baby: 1. SPRO, 2. SLS, 3. MIST, 4. DRTS, 5. SCYX. First 3 have events coming up in next 1 or 2 months that could move the stock either up or down. Last 2 are longer-term plays.

Rolled some of my IRBT gains into RVPH and MIST since they are at a discount today (so close to the catalyst I might add)

MIST

lowkey might buy MIST options but im too high after celebrating green day so idk if its a good idea

Accumulating MIST for the next few weeks. This product launch is going to be huge

Still can't believe how cheap MIST and RVPH are so close to the catalysts - crazy stuff

Done With NFE For Now NFE doing the same thing again. Big pop, zero follow through, straight fade back into the same range. I’m not wasting a full day babysitting that price action. Rotating into stuff that actually respects levels. NXXT holding structure, MIST creeping up, IVDA showing signs of …

MIST climbing…we will hit $5 after the 12/13 announcement

Looking For Runners, Not Red Candles NFE looked ready this morning and then instantly rug pulled. Same story all week. I’m not sitting through another slow-motion fade. Shifting attention to names that actually have buyers: NXXT, MIST, IVDA, BYND. All four have cleaner structures and actual upside if volume sticks. …

NFE Wasted My Time Today NFE had the setup, had the volume, then just… died. Fake breakout, slow bleed, no strength anywhere. I’m done. **There are better charts moving.** * NXXT has a legit reversal pattern. * MIST has been grinding. * IVDA starting to curl. * BYND waking up. …

MIST

MIST - FDA target action date 12/13/25

Na gonna port some more into RVPH and MIST

I’m calling RVPH to a dollar and MIST to $4 by the end of the week FOMO will be unreal for these two

Three Critical Biotech Catalysts: AGIO, BCRX, MIST PDUFA **December 2025 Biotech PDUFA Calendar: AGIO (Dec 7) · BCRX (Dec 12) · MIST (Dec 13)** [**https://www.merlintrader.com/agio-bcrx-mist-december-7-13-2025-three-biotech-pdufa-catalysts-complete-analysis/**](https://www.merlintrader.com/agio-bcrx-mist-december-7-13-2025-three-biotech-pdufa-catalysts-complete-analysis/)